Research and Development

Vraylar (cariprazine), a drug developed as part of a partnership between Allergan and Gedeon Richter, has demonstrated strong results at …

With access to rare disease treatments coming under increasing attention, both in the EU and the US, Pharmafile.com took the …

There was a time when PD-1/L1 immunotherapy treatments could do no wrong, blasting through indication after indication. However, the limits …

Cancer Research UK has announced that its subsidiary, Cancer Research Technology (CRT), and Celgene have agreed a drug discovery collaboration. …

Just 10 days away from Christmas, and big news is still flowing in the industry. Sanofi remains embroiled in scandal …

Pharmafile.com sat down with Dr Rav Seeruthun, Medical Director of Roche UK, to discuss his career thus far and the lessons …

A team of clinical researchers at Barts Health NHS Trust and Queen Mary University of London have reported that a …

Shortly following its announcement of Philippe Mazas as Chief Information Officer, Mundipharma has revealed it has appointed Alberto Martinez as …

In news that Sanofi will no doubt be hoping should divert attention away from the Dengvaxia scandal, the company revealed …

The FDA’s first comprehensive analysis of clinical trial enrolment in older patients with blood cancers has revealed that the population …

The FDA has taken action on Coco Loko and Legal Lean Syrup, both made by Arco Globus Trading LLC, after …

Johnson and Johnson has revealed data which demonstrates that Darzalex (daratumumab), when combined with a regimen of bortezomib, melphalan and …

In the latest addition to a number of high profile exits from Teva, previous interim Chief Executive and the company’s …

A team of researchers at the University of Maryland School of Medicine (UMSOM) has been assessing the effectiveness of a …

Ionis Pharmaceuticals has revealed findings from its Phase 1/2a study into a treatment for Huntington’s disease and the strong data …